Related Experiment Video
Updated: May 10, 2026

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
Published on: September 14, 2013
Clostridium difficile Infection
Christopher L Knight1, Christina M Surawicz
1Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, 4245 Roosevelt Way Northeast, Box 354760, Seattle, WA 98109, USA. cknight@uw.edu
Clostridium difficile infection (CDI) is a growing cause of infectious diarrhea, driven by a resistant new strain. Treatment varies by severity, with fecal transplants showing promise for recurrent cases.
Area of Science:
- Microbiology
- Infectious Diseases
- Gastroenterology
Background:
- Clostridium difficile is a significant cause of infectious diarrhea.
- Incidence has risen sharply since 2000, linked to a novel, more virulent strain.
- This strain exhibits enhanced toxin production and antibiotic resistance.
Purpose of the Study:
- To summarize the current understanding of Clostridium difficile infection (CDI).
- To outline treatment strategies for CDI based on disease severity.
- To highlight emerging therapies and prevention methods for CDI.
Main Methods:
- Review of current literature on Clostridium difficile.
- Analysis of epidemiological trends in CDI incidence.
- Evaluation of treatment guidelines and emerging therapeutic options.
Main Results:
- Oral metronidazole is recommended for mild to moderate CDI.
- Vancomycin, with potential intravenous metronidazole, is indicated for severe CDI.
- Fecal microbiota transplantation (FMT) shows promise for recurrent CDI.
Conclusions:
- Effective management of CDI requires tailored treatment approaches.
- Fecal microbiota transplantation represents a promising option for refractory CDI.
- Preventing nosocomial transmission is critical for controlling CDI outbreaks.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Bacterial Gastroenteritis
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
